medical biomaterial Articles
-
Bioactive compounds obtained by immobilisation of serine protease inhibitors
We studied the preparation of polymeric membranes formed of solutions of poly–3–hydroxybutyrate (PHB) and chitosan. PHB–chitosan biomaterials from these solutions may form various structural types, which determine the biodegradation time, the adsorption capacity, and the kinetics of the release of medicinal compounds from polymeric matrices. Serine protease inhibitors, SERPINs, continue to catch ...
-
Evonik Enhances Glycolide-Based Polymer Portfolio for Medical-Textile Materials
Evonik has announced the signing of an exclusive global agreement with ITV Denkendorf Produktservice (ITVP), a German-based R&D and manufacturing leader for medical-textile materials. New Platform of Glycolide-based Polymers Under the agreement, Evonik will expand its market-leading RESOMER® portfolio with the launch of a new platform of glycolide-based polymers suitable to produce ...
-
Tepha - case study
Tepha Inc. is a medical device firm that develops and commercializes innovative products based on the company’s proprietary PHA (polyhydroxyalkanoate) bioaterial technology. Tepha began working with POS in 2002 to develop its biopolymer resin production processes. These novel process had not yet been demonstrated at the pilot plant scale when the company started working with POS. Today, ...
-
Development of mRNA-Directed Delivery - LNP Delivery System
During the COVID-19 pandemic, the success of mRNA vaccines has greatly propelled the development of mRNA therapeutics. mRNA is a negatively charged nucleic acid that serves as a template for protein synthesis in ribosomes. Despite its utility, the instability of mRNA necessitates appropriate carriers for in vivo delivery. Currently, lipid nanoparticles (LNPs) are the most mature approach for ...
By BOC Sciences
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you